TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.99 CNY | +1.72% |
|
+1.98% | +6.95% |
| Apr. 30 | Tianjin Pharmaceutical's Q1 Profit, Revenue Fall 3% | MT |
| Apr. 30 | Tianjin Pharmaceutical's Q1 Attributable Profit Slips 3% | MT |
Evolution of the average Target Price on Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Price target over the last 5 years
History of analyst recommendation changes
04ecd31ee3be2db.ztcSRRem2y87MBFhxj1znsptezOR5f8NBWn5cVy-I8w.o_pcE37TgWUDfzwvkW8X_-cADXW8q8ZpQA_UOS7fG4OZv3c2IurjSUt5QA~abd2cecc41849ddef90b7d9a7309f3e5
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
35.99
CNY
Average target price
45.8
CNY
Spread / Average Target
+27.26%
High Price Target
45.8
CNY
Spread / Highest target
+27.26%
Low Price Target
45.8
CNY
Spread / Lowest Target
+27.26%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600329 Stock
- Consensus Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited